Our third quarter edition features leading insights from key opinion leaders with findings specific to global and local concerns for clinical trials, manufacturing, and the supply chain; next-generation therapies and technologies; and drug development.
Impacts of Glocalization on the Pharmaceutical Industry, Nigel Walker
Is the U.S. Biosimilars Market Poised for Takeoff?; Haig Barrett
Production of AAV Vectors Using Suspension Mammalian and Insect Cell Systems; Thermo Fisher Scientific, Richard Snyder
Managing the Complexities of International Clinical Trials, Yourway, Gulam Jaffer
Growing With a Flexible, Collaborative CDMO; Grifols Recombinant Protein CDMO Services, Kim Berger, Paul Magreta
Tech Transfer and Scale-Up for Custom APIs Driven by a Collaborative Culture; Albermarle Fine Chemistry Services
Reducing Project Timelines with Integrated Cleanroom Solutions; Environmental Systems Corporation
Executive Compensation: Essential Factor in Private Equity Transactions; Castleford Capital, Jeffrey Marlough
Realizing Technology Transfer in a Successful and Sustainable Manner; Joerg Zimmermann
True Integration is Integral to Providing One-Stop-Shop CDMO Services, Piramal Pharma Solutions
Supporting Commercial Manufacturing of Semisolid Dosage Forms; UPM Pharmaceuticals
Meeting the Need for Higher Containment; Servier
New Trends in Tech Impacting Pharma Facility Design and Construction; CRB
Glocalization: Introduction to the Networking Issue Feature
Glocalization, The Relevance of Global Clinical Trials,
Glocalization of Drug Manufacturing
Glocalization of Drug Manufacturing
Applying an Established and Continuously Upgraded Global Network for CDMO Services; Aspen Pharmacare
Rigorous Quality Controls for Cold-Chain Drug Shipments; Boyle Transportation
Internationalization of a European CDMO; Doppel Pharma CDMO
Harnessing the Gut–Brain Axis to Treat Neurological Disorders; Axial Biotherapeutics
Mimicking Environmental Enrichment for Migraine Therapy, Seurat Therapeutics,
Developing a Microbiome-Based Treatment for Food Allergies; ClostraBio
Personalizing Cancer Treatment with Genomics Technology
Leveraging Biosynthetic Expertise to Access a Wide Portfolio of Cannabinoids
Looking Beyond Current Treatments for CNS Diseases and Disorders; VistaGen Therapeutics
Focusing on the Tumor Microenvironment Leads to Novel Drug Targets
Facilitating Modern Bioprocessing with Real-Time Protein Titer Monitoring; IDEX Health & Science, Kurt Pickle
Choosing the Right Expression Platform for Biologics; Nice Insight
Stabilizing and Protecting Biologic Formulations; LEUKOCARE AG
Expanding Access to Oral Thin Film Technolog; tesa Labtec GmbH
Strategizing for International Business Development; Sosna + Co.
Updating Ethical Guidelines for Cancer Clinical Trials
Facilitating Pharmaceutical and Biotech Facility Acquisitions, PharmaBioSource, Inc.
Living in Canada’s Coastal Paradise; BioVectra
iPSCs: Moving from Drug Testing to Novel Cell Therapies; Stemson Therapeutics
Achieving Rapid Success with a Flexible, Client-Centric Approach; Samsung Biologics
Solving the Industry’s Capacity Utilization Problem; TriRx
Supporting Customers with an Integrated Fermentation Offering; Olon Group
Creating a Global CDMO Focused on Quality, Innovation and Happiness; SK Pharmteco
Alternative Vial Designs to Reduce Lyo-Breakage Risk; SGD Pharma
Global Compliance, Roundtable
Roundtable, Regulatory Harmonization
Northway Biotechpharma Celebrates 15 Years of Growth and Success
.svg)
